Javascript is not enabled in your web browser

This site uses javascript to enhance your browsing experience. Our vision tests require javascript and will not work properly if javascript is disabled. Please enable javascript in your web browser to access all features of this site.

Welcome to MyVisionTest.com, where patients with macular degeneration and other macular diseases can test their vision online. We offer our services free of charge. To use our test online you must first register here. Read the tutorial to learn more.

This site has been designed to be accessible by the visually impaired. Should you have any difficulties, please contact us.

TEST YOUR VISION NOW

Featured Articles

Select Article:
Neil Ford uses ZoomText to enlarge the type on his computer

Low vision self-management program improves outcomes

Self-management techniques represent an important step forward in care of persons with chronic disease. While many multi-disciplinary low vision programs have long incorporated some features of self-management, broader recognition of effective self-management techniques will hopefully increase and expand their use by the low vision care community.

Central Serous Chorioretinopathy

Avastin effective for persistent central serous chorioretinopathy

CSC is normally a self-limiting disease, resolving without treatment within a period of months. However, for those cases that are chronic, a safe and effective treatment is welcome. PDT has been the standard treatment for chronic CSC, but there are concerns regarding potential adverse effects, including chorioretinal atrophy. Anti-VEGF drugs may...

Age-related macular degeneration

Avastin and Lucentis produce same vision outcomes for AMD

This is yet another in a series of recent papers reporting on Avastin vs Lucentis comparisons. To date, no study has found any significant difference in clinical efficacy. However, like the current study, no study has been large enough, nor sufficiently long in duration to find small but potentially important differences in safety. While these...

Central Serous Chorioretinopathy

Low-fluence vs standard-fluence PDT for central serous chorioretinopathy

Most patients with CSC recover spontaneously without need for treatment, but patients with chronic CSC have faced a dilemma: treatment could speed recovery, but carried a risk of causing permanent vision impairment. Now it appears that safety-enhanced PDT may offer a low-risk alternative that is nearly as effective as standard PDT.

Recent News

Retinal angiomatous proliferation
Feb 25, 2010
Compared with combination therapy of intravitreal triamcinolone (IVTA) plus photodynamic therapy (PDT), intravitreal Avastin (IVB) plus PDT was significantly more effective in maintaining and improving visual acuity and in reducing the number of treatment for patients with retinal angiomatous proliferation (RAP), according to a new study....

Full Article


Central Serous Chorioretinopathy
Feb 24, 2010
Photodynamic therapy (PDT) is not effective in eyes with chronic central serous chorioretinopathy (CSC) without intense hyperfluorescence on indocyanine green angiography (ICGA), according to a new study. Central serous chorioretinopathy (CSC) is commonly seen in young or middle-aged adults as localized detachment of the neurosensory retina....

Full Article


Age-related macular degeneration
Feb 24, 2010
There is no difference in the visual acuity (VA) outcomes after Avastin (bevacizumab) or Lucentis (ranibizumab) treatment for AMD, according to a new study. In 2006, the United States Food and Drug Administration approved the use of Lucentis (ranibizumab) for the treatment of exudative AMD. Before its approval, many ophthalmologists already...

Full Article


News Topics

ADL skills adverse drug effects AMD animal study AREDS Avastin blindness brain science cardiovascular disease cataract CATT central serous chorioretinopathy choroid ciliary neurotrophic factor clinical trial CNV combo therapy complement depression diabetes diabetic retinopathy diet dosing strategy drug delivery dry AMD eccentric viewing endophthalmitis eye drops fish fluorescein angiography fundus autofluorescence genetics Germany histoplasmosis ICGA integrin Japan laser photocoagulation lipofuscin low vision Lucentis lutein Macugen macular edema microplasmin mobility myopia neuroprotection OCT oxidative stress PDGF photodynamic therapy pigment epithelial detachment polypoidal choroidal vasculopathy prognosis PrONTO Quality of life radiation reading skills retinal angiomatous proliferation retinal degeneration retinal prosthesis retinal vein occlusion retinitis pigmentosa RNA interference RPE stem cells steroid sunlight surgery tobacco UK uveitis VEGF VEGF Trap vision test visual cycle vitreous wet AMD women
More topics

About MyVisionTest

MyVisionTest.com has been developed to supplement the traditional Amsler Grid for those patients that have been instructed by their eye doctor to monitor their vision at home. MyVisionTest employs a technique known as entoptic perimetry to detect defects in your vision. Research has found entoptic perimetry to be superior to the traditional Amsler grid in detecting such defects. We also offer you the ability to save and review past test results, making it easier for you to detect changes in your vision over time.

Learn more

MyVisionTest Tutorial

If you are new to MyVisionTest, please take a moment to review our tutorial and try out the demo. The vision test requires that you have free multimedia software (Flash) installed and properly configured on your computer. If you are uncertain whether this software is currently installed on your computer, please take a moment to use our troubleshooter to test your system for compatibility with MyVisionTest.

View the MyVisionTest Tutorial

Test your computer for compatibility with MyVisionTest

MyVisionTest Demonstration Mode

Download Amsler Grid